Full exam for Technology for Regenerative Medicine in the Biomedical Engineering degree programme at Politecnico di Milano. The document covers: 1 You can view your results TOMORROW AFTERNOON, Friday July 21st 2017, from 3 PM to 4 PM, at Prof. Raimondi’s office, building n. 6 “Giulio Natta”, North tower, second floor. Surname________________ Name ________________registration (matricola)_____________ Technologies for
Full exam for Technology for Regenerative Medicine in the Biomedical Engineering degree programme at Politecnico di Milano. The document covers: 1 You can view your results TOMORROW AFTERNOON, Friday July 21st 2017, from 3 PM to 4 PM, at Prof. Raimondi’s office, building n. 6 “Giulio Natta”, North tower, second floor. Surname________________ Name ________________registration (matricola)_____________ Technologies for
Import quality: text was extracted directly from the original document.
Representative passages recognised in different parts of the material. The full extracted text remains available to search, while this compact preview makes the page easier to read.
1 You can view your results TOMORROW AFTERNOON, Friday July 21st 2017, from 3 PM to 4 PM, at Prof. Raimondi’s office, building n. 6 “Giulio Natta”, North tower, second floor. Surname________________ Name ________________registration (matricola)_____________ Technologies for regenerative medicine - Prof. Manuela T. Raimondi Examination theme – July 18th, 2017 Read the text below and answer, point by point, to the related questions. BIOARTIFICIAL PANCREAS Let us consider a bioartificial pancreas modelled in vitro, that in the future could be anastomosed to a patient to function as an intravascular bioartificial pancreas. The device can be modelled as a cylindrical cartridge containing pancreatic β cells embedded in a hydrogel called “matrigel”. The device is designed to be connected to the blood vessel of a patient through lateral tubes. The cartridge is composed by a central cylinder filled with cells embedded in matrigel, coaxial to an internal tube running inside the first cylinder and connected to two lateral tubes connected to a culture medium perfusion system. Within the device, the insulin synthesised by the β cells diffuses into the culture medium stream. The culture medium and the cell-loaded matrigel are separated by a semi-permeable membrane of average porosity of 10 nm. The external membrane of the cartridge surrounding the cell-loaded hydrogel is impermeable. The oxygen concentration in the culture medium is c0. The device is currently being tested in vitro and, if successful also in pre-clinical models, it will be anastomosed to the blood vessels of patients with no functional β cells. Answer briefly to the questions in the table (points 5/33): What is the therapeutic product described above? the device comprising a cartridge containing matrigel and cells…
First page of the document.
